Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03282344
Title A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

malignant fibrous histiocytoma

osteosarcoma

pleomorphic liposarcoma

angiosarcoma

chondrosarcoma

leiomyosarcoma

Therapies

Nivolumab + NKTR-214

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.